Genoskin

21/11/2025

🔬 Behind the Scenes: How skin models are shipped worldwide

Watch our new behind-the-scenes video to discover the dedicated packaging that keeps our skin models safe from shocks, temperature fluctuations, and the challenges of long-distance transport.

14/11/2025

🎥 Behind the Skin - Who's behind the models?

In this Behind the Scenes episode, we sit down with Anne, one of our talented production technicians, for a closer look at our daily work in the lab. She shares insights into her role and even a few fun facts along the way!

👉 Watch the first part of Anne’s portrait and the passion that drives our production team

30/10/2025

🔬 Behind the Scenes: How We Create High-Quality Human Skin Models for Research

At Genoskin, precision and care are at the heart of our process. From punching the skin to preparing the matrix, every step is carefully standardized to ensure reliable, reproducible results.
In this quick video, see how we bring our models to life, ensuring they meet the highest standards of quality and relevance for your research.

📹 Watch the process in action!

23/10/2025

🔬 Ever wondered how real human skin models are prepared for scientific use?

At Genoskin, every sample we produce undergoes strict sterile processing and safety testing to ensure the highest level of biosafety and scientific reliability.
From donor screening to sterile laminar flow hoods, our teams follow rigorous protocols to deliver research-ready models you can trust.

🎥 Take a behind-the-scenes look at how we turn donated human skin into powerful tools for drug, vaccine, and cosmetic testing.

01/10/2025

Psoriasis is a complex disease that demands innovative solutions for treatment.

We leverage InflammaSkin, a unique model that replicates complex T cell-mediated inflammation, offering accuracy for psoriasis research.

Why should you choose InflammaSkin for your psoriasis studies:

- Human-relevant skin models that replicate the early inflammatory stages of the disease
- In situ T cell activation and Th1/Th17 phenotype for more precise insights
- Custom assays to study biological markers at the tissue or cell level
- Actionable results with clear, reproducible data to drive your research forward

If you're looking to advance your psoriasis research and accelerate the development of new treatments, let’s start the conversation.

https://eu1.hubs.ly/H0nnND10

17/09/2025

🔁 Missed the live session? The replay is now available!

In this webinar, Pr. Pierre Bruhns (Institut Pasteur) explores how drug-specific antibodies from patients allergic to neuromuscular blockers like rocuronium may help us better understand anaphylaxis—and even guide new therapeutic and diagnostic strategies.

🎯 A must-watch for anyone in immunology, allergy research, or drug development.

🎥 Watch the replay here → https://bit.ly/4nfHwu0

09/09/2025

Going live tomorrow!

Join us for a session with Pr. Pierre Bruhns as he presents how antibody repertoires from allergic patients may lead to better tools for managing drug-induced reactions.

📆 September 10
🕔 8am PT | 11am EST | 5pm CET

🔗 Register now before it’s too late: https://eu1.hubs.ly/H0myF_l0

05/09/2025

Not all antibodies are bad news.

In rare cases, allergy-related antibodies could offer a path to new treatments. This webinar with Pr. Pierre Bruhns explores how antibody specificity and immune memory might help reverse drug effects or guide diagnostics.

Don’t miss it: https://eu1.hubs.ly/H0myKn90

📆 September 10
🕔 8am PT | 11am EST | 5pm CET

03/09/2025

Study local immune reactions without waiting for clinical trials.

HypoSkin® is Genoskin’s injectable, ex vivo human skin model, designed to help you evaluate efficacy, safety, and immune responses in a human-relevant system.

Here’s how it can accelerate your research:
1️⃣ Human-relevant data: Assess local immune reactions in preserved, immunocompetent skin.
2️⃣ Flexible administration: Test subcutaneous, intradermal, or topical delivery of drugs, biologics, and devices.
3️⃣ Deep immune profiling: Leverage flow cytometry, cytokine analysis, and single-cell RNA sequencing for robust immune insights.
4️⃣ Efficient & ethical: Reduce reliance on animal models, save time, and optimize R&D costs.
5️⃣ Regulatory support: Generate reproducible preclinical data that complements in vivo and clinical studies.

If your work involves injectables, HypoSkin® helps you move from concept to clinical readiness faster and with greater confidence.
🔗 Learn more: https://bit.ly/4ngOwq6

02/09/2025

Anaphylaxis from rocuronium? There’s more to the story.

Some allergic reactions to neuromuscular blockers might be driven by pre-existing antibodies. Pr. Pierre Bruhns will walk us through how his team identified these antibodies—and how they might be used to improve therapeutic strategies.

📆 Live on September 10
Register here: https://eu1.hubs.ly/H0myF_90

29/08/2025

✨ The future of drug development is human-relevant, ethical, and already here.

Behind every failed clinical trial are patients still waiting for answers.
Too often, drugs that looked “safe” in animals don’t translate to humans.

What if we could change that by studying new treatments directly in living human skin, before they ever reach a patient?

In our latest Substack post, we share how immunocompetent skin is becoming a powerful tool to:
✨ Predict human immune responses
✨ Reduce reliance on animal testing
✨ De-risk innovation in drug and vaccine development

🔬 Read more on our Substack ⬇️

Bridging the gap between preclinical models and clinical trials with living human skin.

27/08/2025

What if allergic reactions could help us design better therapies?

Join Pr. Pierre Bruhns on September 10 for a live webinar where he’ll share new findings on antibody repertoires from patients allergic to neuromuscular blockers like rocuronium. These insights could change how we think about diagnostics and drug safety.

Save your seat now: https://eu1.hubs.ly/H0myFyn0